Aditxt, Inc.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on this 31 st day of March 2025.
| Aditxt, Inc. | ||
| By: | /s/ Amro Albanna | |
| Name: | Amro Albanna | |
| Title: | Chief Executive Officer | |
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Amro Albanna and Thomas J. Farley, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place, or stead, in any and all capacities, to sign any and all amendments to this Report, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1934, this annual report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Amro Albanna | Chief Executive Officer | March 31, 2025 |
| Amro Albanna | (Principal Executive Officer) | |
| /s/ Thomas J. Farley | Chief Financial Officer | March 31, 2025 |
| Thomas J. Farley | (Principal Financial and Accounting Officer) | |
| /s/ Brian Brady | Director | March 31, 2025 |
| Brian Brady | ||
| /s/ Sylvia Hermina | Director | March 31, 2025 |
| Sylvia Hermina | ||
| /s/ Charles Nelson | Director | March 31, 2025 |
| Charles Nelson | ||
| /s/ Jeffrey W. Runge, M.D. | Director | March 31, 2025 |
| Jeffrey W. Runge, M.D. | ||
| /s/ Shahrokh Shabahang | Chief Innovation Officer and Director | March 31, 2025 |
| Shahrokh Shabahang | ||
CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED
DECEMBER 31, 2024 AND 2023
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID# 3501) | F-2 |
|---|---|
| Consolidated Balance Sheets | F-3 |
| Consolidated Statements of Operations | F-4 |
| Consolidated Statements of Stockholders’ Equity | F-5 |
| Consolidated Statements of Cash Flows | F-7 |
| Consolidated Notes to Financial Statements | F-8 |
PART I - FINANCIAL INFORMATION
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.